Upon application, dissolving microneedles penetrate the stratum corneum, the outermost layer of the skin, and dissolve within minutes to hours, depending on the formulation. This process releases the encapsulated drug or vaccine directly into the dermal or subdermal layers, bypassing the traditional barriers associated with transdermal delivery. The controlled release of the active compounds ensures a sustained therapeutic effect, enhancing patient compliance and treatment outcomes.
